Panlilio L V, Schindler C W
Preclinical Pharmacology Section, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2000 May;150(1):61-6. doi: 10.1007/s002130000415.
Remifentanil is a mu-opioid agonist with an exceptionally short duration of action. Evaluating remifentanil's effects within the self-administration model of drug abuse may provide insight into the relationship between a drug's duration of action and its effectiveness as a reinforcer.
This study was conducted to establish a dose-effect function for intravenous remifentanil self-administration in rats and to assess the drug's ability to maintain responding under intermittent schedules of reinforcement.
Inter-infusion intervals were recorded under two continuous-reinforcement schedules of remifentanil self-administration. In the fixed-dose schedule, the unit dose (0.25-32 micrograms/kg) was held constant within sessions but varied across sessions. In the variable-dose schedule, four different doses were self-administered in random order within each session. For comparison, heroin (6.25-125 micrograms/kg) was studied with the variable-dose schedule. Remifentanil and heroin were also compared under a progressive-ratio schedule of reinforcement in which the response requirements increased exponentially with each successive infusion until responding ceased within each session.
Under the continuous-reinforcement schedules, inter-infusion intervals for both drugs increased monotonically as a function of dose, with the remifentanil curve being considerably flatter. Under the progressive-ratio schedule, breaking points varied as an inverted-U shaped function, and the highest breaking points maintained by remifentanil and heroin were similar. At the doses that maintained the highest breaking points under the progressive-ratio schedule, post-infusion pauses under the continuous-reinforcement schedule were about three times shorter with remifentanil than with heroin.
Although rates of self-administration are clearly influenced by a drug's duration of action, the ability to maintain responding under intermittent schedules of reinforcement may be independent of duration of action.
瑞芬太尼是一种μ阿片受体激动剂,作用持续时间极短。在药物滥用的自我给药模型中评估瑞芬太尼的效果,可能有助于深入了解药物作用持续时间与其作为强化剂有效性之间的关系。
本研究旨在建立大鼠静脉注射瑞芬太尼自我给药的剂量效应函数,并评估该药物在间歇性强化程序下维持反应的能力。
在瑞芬太尼自我给药的两种连续强化程序下记录输注间隔时间。在固定剂量程序中,单位剂量(0.25 - 32微克/千克)在各实验时段内保持恒定,但在不同实验时段之间变化。在可变剂量程序中,每次实验时段内以随机顺序自我给药四种不同剂量。为作比较,采用可变剂量程序研究海洛因(6.25 - 125微克/千克)。还在累进比率强化程序下比较瑞芬太尼和海洛因,在此程序中,每次连续输注的反应要求呈指数增加,直至每次实验时段内反应停止。
在连续强化程序下,两种药物的输注间隔时间均随剂量呈单调增加,瑞芬太尼的曲线较为平缓。在累进比率程序下,断点呈倒U形函数变化,瑞芬太尼和海洛因维持的最高断点相似。在累进比率程序下维持最高断点的剂量时,连续强化程序下瑞芬太尼输注后的停顿时间比海洛因短约三倍。
虽然自我给药率显然受药物作用持续时间影响,但在间歇性强化程序下维持反应的能力可能与作用持续时间无关。